These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3000406)

  • 1. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of infections caused by AIDS and hepatitis B viruses in jailed people.
    Crovari P; Cassini U; Infante D; Guano F; Icardi GC; Auteri G; Di Ponzio A; Cuneo Crovari P
    Boll Ist Sieroter Milan; 1985; 64(5):367-70. PubMed ID: 3004543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of anti-LAV/HTLV III antibodies in groups at risk of infection and in donors blood in the province of Catania].
    Mauro L; Ciccia M; Romeo MA; Di Gregorio F; Sciacca S; Maccarrone S
    Boll Ist Sieroter Milan; 1987; 66(3):194-7. PubMed ID: 3435650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
    De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
    Cooke FJ; Geretti AM; Zuckerman M
    J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance.
    Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 17. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
    De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
    Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.